| Viruses transfer the antiviral second messenger cGAMP between cells A Bridgeman, J Maelfait, T Davenne, T Partridge, Y Peng, A Mayer, ... Science 349 (6253), 1228-1232, 2015 | 253 | 2015 |
| Why don’t we have an effective tuberculosis vaccine yet? T Davenne, H McShane Expert review of vaccines 15 (8), 1009-1013, 2016 | 93 | 2016 |
| A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime–MVA85A boost in healthy UK adults M Wilkie, I Satti, A Minhinnick, S Harris, M Riste, RL Ramon, S Sheehan, ... Vaccine 38 (4), 779-789, 2020 | 91 | 2020 |
| Varicella‐Zoster virus ORF9 is an antagonist of the DNA sensor cGAS J Hertzog, W Zhou, G Fowler, RE Rigby, A Bridgeman, HTW Blest, C Cursi, ... The EMBO journal 41 (14), e109217, 2022 | 32 | 2022 |
| A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis PAC Wing, T Davenne, J Wettengel, AG Lai, X Zhuang, A Chakraborty, ... Life science alliance 2 (2), 2019 | 26 | 2019 |
| Deoxyguanosine is a TLR7 agonist T Davenne, A Bridgeman, RE Rigby, J Rehwinkel European journal of immunology 50 (1), 56-62, 2020 | 25 | 2020 |
| SAMHD1 limits the efficacy of forodesine in leukemia by protecting cells against the cytotoxicity of dGTP T Davenne, J Klintman, S Sharma, RE Rigby, HTW Blest, C Cursi, ... Cell reports 31 (6), 2020 | 22 | 2020 |
| Method for preparing viral particles with cyclic dinucleotide and use of said particles for inducing immune response N Manel, M Gentili, S Takeshi, J Rehwinkel, A Bridgeman, T Davenne, ... US Patent 10,010,607, 2018 | 21 | 2018 |
| PNP inhibitors selectively kill cancer cells lacking SAMHD1 T Davenne, J Rehwinkel Molecular & cellular oncology 7 (6), 1804308, 2020 | 7 | 2020 |
| Method for preparing viral particles with cyclic dinucleotide and use of said particles for treating cancer N Manel, M Gentili, S Takeshi, J Rehwinkel, A Bridgeman, T Davenne, ... US Patent App. 16/084,991, 2019 | 1 | 2019 |
| Biomarkers and uses of pnp inhibitors T Davenne, J REHWINKLE | | 2020 |
| Method for preparing viral particles with cyclic dinucleotide and use of said particles for inducing immune response N Manel, M Gentili, S Takeshi, J Rehwinkel, A Bridgeman, T Davenne, ... US Patent App. 16/021,065, 2018 | | 2018 |
| Characterisation of SAMHD1's ancestral function T Davenne University of Oxford, 2018 | | 2018 |
| HIV-1 particles transfer the antiviral second messenger cGAMP between cells A Bridgeman, J Maelfait, T Davenne, J Rehwinkel 第九届全国免疫学学术大会论文集, 2014 | | 2014 |
